Vision and Mission
Our ‘better health through best evidence’ vision is for a self-improving Australian healthcare system.
Why ACTA formed
Until ACTA, there was no single, coordinated mechanism to connect clinical researchers with governments, health care policymakers and consumers on issues that impact the conduct of investigator-led clinical trials across the Australian health system.
ACTA’s Activity Plan outlines key activities to be undertaken to strengthen the capacity, efficiency and effectiveness of clinical trials networks through the Australian Clinical Trials Alliance program.
Current ACTA Members
Australian Clinical Trials Alliance is a membership-based organisation. There are 74 Member Networks and more than 140 Individual Members.
The Board of Directors is responsible for the corporate governance and financial management of the organisation.
The team at ACTA Central (and Nicola, based at the George Institute in Sydney) keep all the wheels spinning.
ACTA develops strong partnerships and models of engagement with stakeholders that share ACTA’s mission.
Funding and Support
With a $5 million Medical Research Future Fund (MRFF) grant to ACTA in 2017, the Commonwealth Government demonstrated its commitment to health and medical research focused on improving patient outcomes and advancing evidence-based healthcare.
Find ACTA’s policies, including its constitution and board charter here.
What is a Clinical Trials Network?
Clinical Trials Networks (CTNs) are collaborative groups of practising clinician-researchers. While some trials are conducted in collaboration with industry, the majority focus on investigator-initiated trials…
Do you want to be part of the ACTA Community? Check here for opportunities within ACTA and our Member Organisations.
Find ACTA’s Annual Reports and corporate publications here.